Skip to content

Amylyx Pharmaceuticals, Inc. AMLX Deposits And Other Assets

Deposits And Other Assets at other companies

American Homes 4 Rent logo
American Homes 4 RentAMH
$239.1M-21.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$22.65M+5.7%
IQVIA logo
IQVIAIQV
$489M+0.8%
DraftKings Inc. logo
DraftKings Inc.DKNG
$106.35M-9.0%
MicroStrategy logo
MicroStrategyMSTR
$136.26M+63.7%
ADMA Biologics logo
ADMA BiologicsADMA
$8.47M+3.4%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$43.8M-15.8%
Net income-$41.3M-15.0%
EPS (diluted)-$0.37+11.9%

Balance sheet

See full
Cash & equivalents$229.1M+283%
Total debt$5.6M+307%
Total equity$273.2M+35.6%
Total assets$293.6M+33.7%

Cash flow

See full
Operating cash flow-$36.9M+7.4%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$1.89B+390%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-63.3%-12.2pp
Debt / equity0.0×
Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept amlx:DepositsAndOtherAssets.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s deposits and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s deposits and other assets?
Amylyx Pharmaceuticals, Inc. (AMLX) reported deposits and other assets of $2.5M in Q4 2025.
What does deposits and other assets mean?
This category encompasses long-term financial deposits and miscellaneous non-current assets that do not fit into standard asset classifications like property or intangible assets. It often includes security deposits for facilities, long-term prepayments, or other non-operating receivables expected to be realized beyond the next twelve months. Tracking this balance helps investors understand the allocation of capital toward non-core operational commitments and long-term contractual arrangements.